Zobrazeno 1 - 10
of 901
pro vyhledávání: '"Jeffrey R, Curtis"'
Autor:
Jeffrey R. Curtis, Atul Deodhar, Enrique R. Soriano, Emmanouil Rampakakis, May Shawi, Natalie J. Shiff, Chenglong Han, William Tillett, Dafna D. Gladman
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 6, Pp 1501-1517 (2024)
Abstract Introduction Patterns of treatment response can inform clinical decision-making. This study assessed the course and impact of achieving minimal clinically important improvement (MCII) in clinical measures and patient-reported outcomes (PROs)
Externí odkaz:
https://doaj.org/article/631e6dc4cc6a4bb893e0571db9fd29f2
Autor:
Jeffrey R. Curtis, Vivian P. Bykerk, Mary K. Crow, Maria I. Danila, Boulos Haraoui, George A. Karpouzas, Eric D. Newman, Hillary Norton, Jeff Peterson, Carter Thorne, Grace C. Wright, Lorna Bain
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 9, Pp 542-552 (2024)
Objective Quality of care (QoC) delivery in rheumatoid arthritis (RA) continues to suffer from various challenges (eg, delay in diagnosis and referral) that can lead to poor patient outcomes. This study aimed to identify good practice interventions t
Externí odkaz:
https://doaj.org/article/336c2dcfb96a4c96919d11e7ae556fa3
Autor:
Jeffrey R Curtis, Jennifer Wang, Joel M Kremer, Srinivasa T Reddy, Dimitrios A Pappas, Christina Charles-Schoeman, David A Elashoff, Rong Guo, Amir A Razmjou, Ani Shahbazian, David Meriwether, Dawoud Sulaiman, Ellen O'Connor
Publikováno v:
RMD Open, Vol 10, Iss 4 (2024)
Objective Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL)-associated enzyme, that has been implicated as a biomarker of cardiovascular risk in patients with rheumatoid arthritis (RA). We aimed to investigate how different biologic therapies
Externí odkaz:
https://doaj.org/article/cb1cbacbb3d949a28b62cbb371d441a6
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss 2 (2024)
Objective This study aimed to validate claims-based algorithms for identifying SLE and lupus nephritis (LN) in Medicare data, enhancing the use of the Lupus Index for geospatial research on SLE prevalence and outcomes.Methods We retrospectively evalu
Externí odkaz:
https://doaj.org/article/f269b2de5f9d4601a2fa43a1f2d251d9
Autor:
Jeffrey R. Curtis, Robert R. McLean, I‐Heng Lee, Rachel H. Mackey, Page C. Moore, Richard Haubrich, Jeffrey D. Greenberg, Alicea Wu
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 5, Pp 253-264 (2024)
Objective To describe and identify associated factors for patient–clinician discordance of disease assessment at biologic or Janus kinase inhibitor (JAKi) initiation and over 12 months following initiation in patients with rheumatoid arthritis (RA)
Externí odkaz:
https://doaj.org/article/6c378415e1284b08b0037905b3d6a940
Autor:
Swamy Venuturupalli, Alexander Peck, Yogamanas Jinka, Natalie Fortune, Nikhil Davuluri, William B. Nowell, Kelly Gavigan, John Cush, Neelkamal Soares, Rebecca Grainger, Jeffrey R. Curtis
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 5, Pp 312-320 (2024)
Objective We performed a scoping review of the relevant literature on home‐based telehealth in rheumatology to understand its appropriate application in rheumatology practice. Methods We searched the Cochrane Library, PubMed, Web of Science, and sc
Externí odkaz:
https://doaj.org/article/6abaa78651ec44bba64465df89d1851f
Autor:
Emily E. Holladay, Amy S. Mudano, Fenglong Xie, Jingyi Zhang, Ted R. Mikuls, Brian LaMoreaux, Lissa Padnick-Silver, Jeffrey R. Curtis
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Background/Purpose Little is known about long-term clinical outcomes or urate-lowering (ULT) therapy use following pegloticase discontinuation. We examined ULT use, serum urate (SU), inflammatory biomarkers, and renal function following pegl
Externí odkaz:
https://doaj.org/article/dacf2495b86f436fb4c85b5bbe55702e
Autor:
Jeffrey R. Curtis, Iain B. McInnes, Proton Rahman, Dafna D. Gladman, Steven Peterson, Feifei Yang, Oluwakayode Adejoro, Alexa P. Kollmeier, Natalie J. Shiff, Chenglong Han, May Shawi, William Tillett, Philip J. Mease
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 2, Pp 425-441 (2024)
Abstract Introduction To evaluate the effect of guselkumab on work productivity and nonwork daily activity impairment and general health status through 2 years in patients who were biologic-naïve with active psoriatic arthritis (PsA) in the phase 3
Externí odkaz:
https://doaj.org/article/0fe4fa79267340eca6264c7603694203
Autor:
Jeffrey R. Curtis, Paul Emery, Bryan Downie, Yan Zhong, Jinfeng Liu, Ling Han, Rachael E. Hawtin, Gerd Rüdiger Burmester
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 1, Pp 177-189 (2023)
Abstract Objectives To assess cigarette smoking’s effects on efficacy of the preferential Janus kinase (JAK) 1 inhibitor filgotinib and drug persistence in patients with rheumatoid arthritis (RA). Methods Efficacy in non-smokers, former smokers, an
Externí odkaz:
https://doaj.org/article/e8bc03cbee46488dacc4d9c58186f5de
Autor:
Jim C Oates, Jeffrey R Curtis
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/617e6da655564cc4bbd9912aa76db2a9